Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New PKP2-based gene therapy for ARVC treatment

Oct. 29, 2021

Targeting IKK-beta in cardiac fibroblasts may protect against heart failure

Oct. 28, 2021

Akebia Therapeutics presents new prolyl 4-hydroxylase inhibitors

Oct. 15, 2021

Knocking down Snai1 rescues right ventricular failure in rats by blockade of EtM transition

Oct. 15, 2021

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Oct. 14, 2021

CD39+ plasmablasts and adenosine identified as drivers of sepsis-induced long-term immunosuppression

Sep. 15, 2021

ORAI1 behind the pathogenesis of pulmonary arterial hypertension

Sep. 14, 2021

New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death

Sep. 9, 2021

Altered Chkb leads to cardiomyopathy, murine model shows

Sep. 6, 2021

New pyrimidinone amides as APJ receptor agonists identified for heart failure

Sep. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...